-
Blog BLOG
-
Product Center BRAND DYNAMICS
-
Investor INVESTOR RELATIONS
-
Contact Us CONTACT
-
Supervise SUPERVISION
A new influenza A drug from Jiankangyuan, requiring only one dose! It has entered Phase III clinical trials, and the raw materials will be produced in Macun District!
Published Time:
2023-11-14
On the morning of November 9th, Jiankangyuan, in collaboration with Jiaozuo No. 2 People's Hospital, held a launch meeting for a Phase III clinical trial of a new influenza drug. Attendees included leaders from Jiaozuo Municipal Health Commission, Macun District, and the hospital, as well as Dr. Jin Fang, Chief Scientist of Jiankangyuan. The group's Phase III clinical trial of TG-1000, a Class I innovative chemical drug for the treatment of influenza, has already begun with 50 participating hospitals, and the project is rapidly entering the enrollment phase. This drug is used to treat patients aged 12 and above with uncomplicated influenza A and B. After TG-1000 is launched, its raw materials will be produced in the high-end raw material project in Macun District, playing an important role in extending, supplementing, and strengthening the biopharmaceutical industry in the district.
In recent years, Macun District has focused on the development advantages of the biopharmaceutical industry, using Jiankangyuan as the leader. Macun District plans to build a biopharmaceutical base, fully undertaking the Shenzhen Jiankangyuan industrial transfer project, extending the pharmaceutical manufacturing industry chain, and striving to create a biopharmaceutical industrial park with a total investment of 5.5 billion yuan and an area of 80 hectares. At the same time, it focuses on building a biopharmaceutical R&D platform driven by leading enterprises, guided by technological innovation, and supported by advantageous products, promoting the implementation of projects such as the Jiankangyuan Biopharmaceutical Research Institute and the Raw Material Research Center, and developing into an innovative highland for the high-quality development of Jiaozuo's biopharmaceutical industry. To date, the district's biopharmaceutical industry has an annual output value of nearly 2 billion yuan.
Influenza (flu) is a contagious respiratory illness caused by influenza viruses. Currently, influenza remains one of the world's most serious public health challenges. According to Dr. Jin Fang, Chief Scientist of Joincare Pharmaceutical Group Industry Co., Ltd., TG-1000 is a prodrug that is converted into the active ingredient TG-0527 through esterase hydrolysis. It inhibits influenza virus polymerase acidic protein endonuclease, thereby inhibiting viral RNA synthesis. It is easy to use and has the advantage of requiring only one dose for a cure.
Source: WeChat Official Account "Charm Macun"
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home